GSK buys full rights to make COVID, influenza vaccines from CureVac
Wednesday, July 3rd 2024, 6:25:52 am
article
The deal is the result of restructuring a collaboration, which began in 2020 to develop mRNA-based vaccines for infectious diseases, into a new licensing agreement, GSK added. As a result of the collaboration, the two companies have vaccine candidates for seasonal influenza and COVID-19 in phase II clinical development and avian influenza in phase I clinical development.
Breaking
https://townhall.com/tipsheet/mattvespa/2026/05/26/rsc-held-an-event-for-this-reporter-who-exposed-an-egregious-medicare-scam-in-ohio-n2676591...
The national average price of regular gas continued its 2026 tradition of fluctuating, with Tuesday's average falling below $4.50 per gallon....
Officers in central Thailand posed as a sparkly dance troupe to arrest a suspected drug dealer accused of narcotics and illegal gambling offenses...
